Hormone Replacement Therapy Does Not Eliminate Risk Factors for Joint Complications following Total Joint Arthroplasty: A Matched Cohort Study
Aging causes a reduction in testosterone and estrogen, which is linked to diminished bone mineral density. Hormone replacement therapy and its effect on the outcome of joint arthroplasties is unclear. The purpose of this study was to analyze the impact of testosterone replacement therapy (TRT) and e...
Main Authors: | Lacee K. Collins, Matthew W. Cole, Timothy L. Waters, Michael Iloanya, Patrick A. Massey, William F. Sherman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Pathophysiology |
Subjects: | |
Online Access: | https://www.mdpi.com/1873-149X/30/2/11 |
Similar Items
-
Incontinence Is an Independent Risk Factor for Total Hip and Knee Arthroplasty
by: Jacob S. Budin, BS, et al.
Published: (2024-06-01) -
Evolution of Concepts: Can Personalized Hip Arthroplasty Improve Joint Stability?
by: Sivan Sivaloganathan, et al.
Published: (2023-05-01) -
Actual versus Forecast Burden of Primary Hip and Knee Replacement Surgery in Australia: Analysis of Data from the Australian Orthopaedic Association National Joint Replacement Registry
by: Ilana N. Ackerman, et al.
Published: (2022-03-01) -
Keeping the Lights On: The Impact of the COVID-19 Pandemic on Elective Total Joint Arthroplasty Utilization in the United States
by: Matthew W. Cole, MD, et al.
Published: (2023-02-01) -
Hormone replacement therapy does not increase thrombosis risk following THA: a national database study
by: Brian P. McCormick, et al.
Published: (2023-01-01)